CI Cigna Group Loading... : Bullish and Bearish Analyst Opinions
Loading chart...
Top Calls
Feed
11:20
Jul 01
Jul 01
Cigna's new CEO Brian Evanko outlines a patient-centered strategy but faces challenges convincing consumers and Wall Street of its profitability.
07:39
Jun 23
Jun 23
RBC initiates coverage of Centene with a Sector Perform rating and a price target of $70.
12:41
May 22
May 22
Cigna stable dividend payer.
Cigna is a large insurance company with stable cash flows and strong free cash flow, making it a reliable dividend payer. Buffett's Berkshire also relies on insurance as a core business.
MED
16:15
May 17
May 17
Cigna undervalued at 9.7x earnings
Cigna is a high-quality health insurer in an oligopolistic sector with predictable earnings growth, strong free cash flow, and a low valuation of 9.7x earnings compared to the market's 23x. The company treats shareholders well via dividends and buybacks. This makes it a resilient holding even during market downturns, and it is significantly undervalued relative to its long-term potential.
HIGH
17:41
May 06
May 06
Andy Constan notes that Cigna was drawn into the LTCM crisis due to inadequate hedging and mismanagement of short calls in VLA products, highlighting historical risk management failures.
HIGH
23:06
Mar 11
Mar 11
Under my plan, I want to stop all payments to big insurance companies and instead give the money directly to the people so that they can buy their own healthcare. Managed care organizations derive a massive portion of their revenue and earnings from government-sponsored programs, including ACA subsidies, Medicare, and Medicaid. Cutting off direct federal payments to these insurers would severely compress their margins, disrupt their revenue base, and force a complete restructuring of the health insurance market. SHORT. The administration is actively targeting the profitability and government funding mechanisms of major managed care companies. Congress blocks the proposed healthcare overhaul, maintaining the status quo for managed care revenues and government subsidies.
00:53
Feb 26
Feb 26
Senator Marshall explicitly mentioned "clipping the wings of the Pharmacy Benefit Managers (PBMs)" and codifying "Trump Rx" / price transparency. PBMs (owned by major insurers like CVS, Cigna, UnitedHealth) rely on opaque pricing models for profit. Legislative momentum to force transparency or reduce their leverage acts as a regulatory headwind for these specific healthcare verticals. WATCH / AVOID PBM-exposed healthcare stocks. Gridlock in Congress prevents legislation from passing.
04:11
Feb 25
Feb 25
"I want to stop all payments to big insurance companies and instead give that money directly to the people... stock prices soared... like nothing else." The administration views the "middleman" model of Managed Care Organizations (MCOs) as the primary driver of healthcare inflation. Shifting federal subsidies (ACA/Medicare) directly to patients bypasses the insurers, threatening their revenue streams and margin compression. SHORT. The political target on the back of the insurance sector is now explicit policy. The lobby for healthcare insurers is powerful; implementation of direct payments may face logistical gridlock.
23:00
Dec 22
Dec 22
1. THE FACT: Trump plans to meet with 14 insurance companies (including health, auto, home) to tell them to cut rates, threatening to "cut them out" if they don't.
2. THE BRIDGE: Direct presidential pressure to cut rates across the insurance sector, particularly health insurance, could significantly compress profit margins and negatively impact earnings for these companies.
3. THE VERDICT: Short or avoid health insurance companies and other insurance providers due to potential government-mandated rate cuts.
About CI Analyst Coverage
Buzzberg tracks CI (Cigna Group) across 8 sources. 2 bullish vs 0 bearish calls from 8 analysts. Sentiment: predominantly bullish (22%). 9 total trade ideas tracked. Latest voices: Bloomberg, FirstSquawk, Dmitry Solodin.